Skip to main content
DexcomEarnings

Dexcom 3Q 2026: Revenue $1.34B, Net income $275.1M, EPS $0.72 - 10-Q Summary

Source: Autobound Signal API · 82 signals tracked for Dexcom · updated

Get Dexcom's live signals in Claude or ChatGPT, or by API

AskWhat changed at Dexcom this week? Use Autobound signals for dexcom.com.

What happened

Dexcom reported third-quarter 2026 net income of $275.1 million.

Source

Article excerpt

Highlighted: the sentence this signal was extracted from

Dexcom 3Q 2026: Revenue $1.34B, Net income $275.1M, EPS $0.72 - 10-Q Summary Less than 1 min read DXCM Dexcom reported third-quarter 2026 revenue of $1.34 billion, up 11.2% year over year, while net income declined 3.1% to $275.1 million and diluted EPS increased 2.9% to $0.72. Financial Highlights Metric Current quarter Prior year quarter YoY change Revenue¹ $1.34B $1.21B 11.2% Net income² $275.1M $283.8M (3.1%) Diluted EPS³ $0.72 $0.7 2.9% ¹ Reported as "Revenue". ² Reported as "Net income". ³ Reported as "Diluted net income per share". Business Highlights Distributor revenue increased to $1.15 billion from $1.03 billion, while direct revenue rose to $196.5 million from $183.3 million. G7 15 Day contributed to stronger gross margin, alongside higher volumes, improved manufacturing efficiency and favorable product mix. Stelo, Dexcom's over-the-counter biosensor, received FDA clearance in June 2026 for children aged 2 and older who do not use insulin. Dexcom plans to scale manufacturing for rising demand and continue investing in product development, connected platforms and predictive CGM insights. Original SEC Filing: DEXCOM INC [ DXCM ] - 10-Q - Oct. 29, 2026 Disclaimer This is an AI-powered summary. It may contain inaccuracies. Consider verifying important information with the source. Please note this summary is solely based on documents filed with the SEC. Earnings...

Keep reading with a free account

The rest of this article, and every signal for Dexcom, is in your free account.

Extracted by Autobound

From the Signal API record
Event
Earnings

What this signalsEarnings results often set the next budget cycle.

Amount named
$275M

The full record

From the Signal API record

Numbers

Amount named in the story
$275M

Extraction

Confidence
95%
Detected
Oct 29, 2026
signal_type
news
signal_subtype
has_earnings

Use this data

Get every earnings signal for Dexcom and the companies you sell to, in the tools you already use.

  1. Ask Claude about it

    Connect Autobound to Claude, Claude Code or Cursor with MCP. Then ask: “What changed at Dexcom this week?”

  2. Send it to your own tools

    The Signal API returns earnings signals for any list of companies as JSON, for your CRM, warehouse or app.

  3. Try it free

    Sign up and spend your free credits on the companies you sell to.

    Start Free1,000 free credits

The API returns more than this page shows

This page shows a preview. The full news record in the Signal API and MCP can also have these 8 fields. Some fields are empty for some signals.

Company

  • linkedin_urlValue in the API
  • industriesValue in the API
  • employee_count_lowValue in the API
  • employee_count_highValue in the API
  • revenueValue in the API
  • descriptionValue in the API

Signal

  • signal_nameValue in the API
  • associationValue in the API
Show the full JSONThe record on this page and the API request

GET /v1/signals/079e9dc0-c053-1deb-99d0-4ba7e88f4ec1 returns this record as JSON. POST /v1/companies/enrich returns every signal for dexcom.com.

{
  "signal_id": "079e9dc0-c053-1deb-99d0-4ba7e88f4ec1",
  "signal_type": "news",
  "signal_subtype": "has_earnings",
  "detected_at": "2026-10-29T21:31:00+00:00",
  "company": {
    "name": "Dexcom",
    "domain": "dexcom.com"
  },
  "data": {
    "url": "https://www.tradingview.com/news/tradingview:7976840c668cd:0-dexcom-3q-2026-revenue-1-34b-net-income-275-1m-eps-0-72-10-q-summary/",
    "title": "Dexcom 3Q 2026: Revenue $1.34B, Net income $275.1M, EPS $0.72 - 10-Q Summary - TradingView",
    "excerpt": "Dexcom 3Q 2026: Revenue $1.34B, Net income $275.1M, EPS $0.72 - 10-Q Summary Less than 1 min read DXCM Dexcom reported third-quarter 2026 revenue of $1.34 billion, up 11.2% year over year, while net income declined 3.1% to $275.1 million and diluted EPS increased 2.9% to $0.72. Financial Highlights Metric Current quarter Prior year quarter YoY change Revenue¹ $1.34B $1.21B 11.2% Net income² $275.1M $283.8M (3.1%) Diluted EPS³ $0.72 $0.7 2.9% ¹ Reported as “Revenue”. ² Reported as “Net income”. ³ Reported as “Diluted net income per share”. Business Highlights Distributor revenue increased to $1.15 billion from $1.03 billion, while direct revenue rose to $196.5 million from $183.3 million. G7 15 Day contributed to stronger gross margin, alongside higher volumes, improved manufacturing efficiency and favorable product mix. Stelo, Dexcom’s over-the-counter biosensor, received FDA clearance in June 2026 for children aged 2 and older who do not use insulin. Dexcom plans to scale manufacturing for rising demand and continue investing in product development, connected platforms and predictive CGM insights. Original SEC Filing: DEXCOM INC [ DXCM ] - 10-Q - Oct. 29, 2026 Disclaimer This is an AI-powered summary. It may contain inaccuracies. Consider verifying important information with the source. Please note this summary is solely based on documents filed with the SEC. Earnings...",
    "summary": "Dexcom reported third-quarter 2026 net income of $275.1 million.",
    "planning": false,
    "image_url": "https://s.tradingview.com/static/images/illustrations/news-story.jpg",
    "confidence": 0.95,
    "published_at": "2026-10-29T21:31:00Z",
    "article_sentence": "Dexcom reported third-quarter 2026 revenue of $1.34 billion, up 11.2% year over year, while net income declined 3.1% to $275.1 million and diluted EPS increased 2.9% to $0.72.",
    "amount_normalized": 275100000
  }
}

Long text fields are shortened on this page.

Looking up one signal by its id is free. Enrich costs 2 credits per signal returned; a call with no results is free.